Celgene Corporation v. Attorney General of Canada

Supreme Court Hearings

Celgene Corporation v. Attorney General of Canada

Celgene Corporation v. Attorney General of Canada – November 10, 2010
Case #33579
The Federal Court of Appeal ruled that Celgene had to provide pricing information for the drug Thalomid, which is a blood-cancer drug and one of the company’s top-selling drugs. Celgene argues that it does not have to provide the information because Thalomid is not sold in Canada. Celgene had shipped the drug to a Canadian doctor to treat a patient in Canada.